MEDIUM confidence: 100% data completeness, but the composite (47) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net insider -$18.6M over 180 days (0 open-market buys, 12 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $4.5B— | $5.9B+32.7% | $5.5B-7.0% | $5.8B+4.7% | $8.2B+42.1% |
| EPS (dil.) | $-0.53— | $-0.19n/m | $-1.08n/m | $-1.02n/m | $3.07n/m |
| Free Cash Flow | $632M— | $1.1B+69.4% | $1.0B-4.8% | $1.4B+36.2% | $1.4B+0.5% |
| Gross Margin | 46.3% | 50.5%+4.2pp | 41.6%-8.8pp | 41.3%-0.3pp | 51.0%+9.7pp |
| Operating Margin | -7.8% | 4.0%+11.8pp | -10.3%-14.3pp | -12.5%-2.2pp | 16.3%+28.8pp |
| Net Margin | -9.4% | -2.8%+6.7pp | -16.9%-14.2pp | -15.3%+1.6pp | 32.6%+47.9pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $248 avg across 35 analysts.
Buy-rated share 85% → 88% over ~3 months (+4pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| May 2026 | $0.80 | $0.80 | +0.3% |
| Mar 2026 | $0.79 | $0.80 | +1.0% |
| Dec 2025 | $0.74 | $0.76 | +2.3% |
| Aug 2025 | $0.67 | $0.67 | -0.4% |
| May 2025 | $0.61 | $0.62 | +1.3% |
| Mar 2025 | $0.59 | $0.60 | +1.7% |
| Dec 2024 | $0.41 | $0.43 | +4.9% |
| Aug 2024 | $0.29 | $0.30 | +2.2% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 17.4%/yr (revenue basis).
Base free cash flow $1.3B (avg FY2024–FY2026; latest year $1.4B) · equity value $190.1B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 47 for MRVL suggests a neutral outlook, driven by a mix of strong growth and momentum, but tempered by high valuation and risk metrics. The stock scores high on growth, with revenue and EPS growth of 42.1% and 403.9%, respectively, and exhibits strong momentum with a 12-month return of 180.9%. However, it trades at a premium, with a P/E of 73.9 and P/B of 10.5, and exhibits high volatility, with a beta of 2.2 and 60-day volatility of 116.5%, contributing to its lower overall score.